Findlay Park Partners LLP Sells 75,100 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• Findlay Park Partners LLP reduced its stake in UnitedHealth Group by 11.5%, making it the firm's 4th largest holding at 3.1% of its portfolio, valued at approximately $301.5 million.
• UnitedHealth Group reported Q2 earnings of $4.08 per share, missing estimates of $4.45, but its revenue increased by 12.9% year-over-year to $111.62 billion.
• The company announced a quarterly dividend of $2.21 per share, resulting in an annualized dividend yield of 2.9% and a payout ratio of 38.30%.

Findlay Park Partners LLP trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 11.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 575,626 shares of the healthcare conglomerate's stock after selling 75,100 shares during the quarter. UnitedHealth Group accounts for 3.1% of Findlay Park Partners LLP's holdings, making the stock its 4th largest holding. Findlay Park Partners LLP owned about 0.06% of UnitedHealth Group worth $301,484,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Kitching Partners LLC acquired a new position in UnitedHealth Group during the 1st quarter worth $254,000. Harvest Portfolios Group Inc. lifted its holdings in UnitedHealth Group by 10.3% during the 1st quarter. Harvest Portfolios Group Inc. now owns 150,694 shares of the healthcare conglomerate's stock worth $78,926,000 after buying an additional 14,061 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec lifted its holdings in UnitedHealth Group by 5.9% during the 1st quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,000,107 shares of the healthcare conglomerate's stock worth $523,806,000 after buying an additional 55,634 shares during the last quarter. Bank of Hawaii lifted its holdings in UnitedHealth Group by 34.9% during the 1st quarter. Bank of Hawaii now owns 1,437 shares of the healthcare conglomerate's stock worth $753,000 after buying an additional 372 shares during the last quarter. Finally, Taikang Asset Management Hong Kong Co Ltd lifted its holdings in UnitedHealth Group by 2.9% during the 1st quarter. Taikang Asset Management Hong Kong Co Ltd now owns 18,498 shares of the healthcare conglomerate's stock worth $9,688,000 after buying an additional 529 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft decreased their price target on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a report on Wednesday, May 14th. Wolfe Research reduced their target price on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a report on Tuesday, May 20th. Truist Financial reduced their target price on UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating for the company in a report on Wednesday, July 16th. TD Cowen downgraded UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price for the company. in a report on Monday, May 19th. Finally, Mizuho reduced their price objective on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a research note on Friday, May 16th. Fifteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and an average price target of $353.00.

UnitedHealth Group Stock Performance

NYSE UNH traded up $3.51 on Wednesday, hitting $303.94. 9,956,016 shares of the company's stock were exchanged, compared to its average volume of 21,825,404. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The firm's 50-day moving average price is $288.09 and its two-hundred day moving average price is $384.83. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The firm has a market cap of $275.27 billion, a price-to-earnings ratio of 13.17, a P/E/G ratio of 1.94 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the previous year, the firm posted $6.80 EPS. The business's revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a dividend of $2.21 per share. The ex-dividend date is Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.9%. UnitedHealth Group's payout ratio is presently 38.30%.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the transaction, the chief executive officer owned 10,398 shares in the company, valued at approximately $3,171,390. The trade was a 5.36% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.28% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.